Abbott Laboratories (ABT) EBITDA Margin Growth (5y) (2014 - 2026)
Powered by 
Analysis
Abbott Laboratories (ABT) EBITDA Margin Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.05 Bn | 178.45 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.38 Bn | 119.17 Bn | 1.96 Bn |
| 3 | Medtronic | 118.39 Bn | 109.58 Bn | 6.34 Bn |
| 4 | Stryker | 105.69 Bn | 102.21 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.59 Bn | 66.05 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.78 Bn | 45.53 Bn | 1.35 Bn |
| 7 | Alcon | 33.98 Bn | 32.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.21 Bn | 30.26 Bn | 830.00 Mn |
| 9 | Steris | 21.12 Bn | 20.64 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.24 Bn | 17.83 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.00 |
| Mar 31, 2026 | -812.00 |
| Dec 31, 2025 | -308.00 |
| Sep 30, 2025 | 121.00 |
| Jun 30, 2025 | 925.00 |
| Mar 31, 2025 | 653.00 |
| Dec 31, 2024 | 71.00 |
| Sep 30, 2024 | 265.00 |
| Jun 30, 2024 | 97.00 |
| Mar 31, 2024 | 410.00 |
| Dec 31, 2023 | 238.00 |
| Sep 30, 2023 | 324.00 |
| Jun 30, 2023 | 410.00 |
| Mar 31, 2023 | 725.00 |
| Dec 31, 2022 | 434.00 |
| Sep 30, 2022 | 574.00 |
| Jun 30, 2022 | 1,529.00 |
| Mar 31, 2022 | 2,830.00 |
| Dec 31, 2021 | 594.00 |
| Sep 30, 2021 | 638.00 |